Q3 EPS Estimates for Core Laboratories Cut by Zacks Research

Core Laboratories Inc. (NYSE:CLB - Free Report) - Research analysts at Zacks Research lowered their Q3 2026 earnings per share (EPS) estimates for Core Laboratories in a research report issued to clients and investors on Tuesday, July 8th. Zacks Research analyst R. Department now anticipates that the oil and gas company will earn $0.16 per share for the quarter, down from their prior forecast of $0.19. The consensus estimate for Core Laboratories' current full-year earnings is $0.96 per share. Zacks Research also issued estimates for Core Laboratories' Q4 2026 earnings at $0.26 EPS, FY2026 earnings at $0.79 EPS and Q1 2027 earnings at $0.20 EPS.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The firm had revenue of $123.59 million for the quarter, compared to analyst estimates of $125.09 million. Core Laboratories had a net margin of 5.41% and a return on equity of 15.06%. Core Laboratories's revenue was down 4.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.19 EPS.

CLB has been the subject of several other reports. Wall Street Zen lowered Core Laboratories from a "hold" rating to a "sell" rating in a research report on Friday, April 25th. Citigroup lowered their price objective on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a research report on Tuesday, May 13th. Finally, Stifel Nicolaus cut their price objective on Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $15.00.

Core Laboratories Trading Down 1.6%

Shares of Core Laboratories stock opened at $12.57 on Thursday. The firm has a market capitalization of $589.28 million, a price-to-earnings ratio of 21.31, a PEG ratio of 3.93 and a beta of 1.41. Core Laboratories has a fifty-two week low of $10.14 and a fifty-two week high of $25.13. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.64 and a current ratio of 2.21. The stock has a 50 day moving average of $11.78 and a 200 day moving average of $14.34.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Rhumbline Advisers grew its stake in shares of Core Laboratories by 1.7% in the 1st quarter. Rhumbline Advisers now owns 138,610 shares of the oil and gas company's stock valued at $2,078,000 after purchasing an additional 2,376 shares during the last quarter. Advisors Capital Management LLC grew its stake in shares of Core Laboratories by 3.3% in the 1st quarter. Advisors Capital Management LLC now owns 238,867 shares of the oil and gas company's stock valued at $3,581,000 after purchasing an additional 7,718 shares during the last quarter. Fred Alger Management LLC grew its stake in shares of Core Laboratories by 32.4% in the 1st quarter. Fred Alger Management LLC now owns 736,853 shares of the oil and gas company's stock valued at $11,045,000 after purchasing an additional 180,344 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Core Laboratories by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 27,893 shares of the oil and gas company's stock valued at $418,000 after purchasing an additional 1,170 shares during the last quarter. Finally, Ariel Investments LLC grew its stake in shares of Core Laboratories by 7.4% in the 1st quarter. Ariel Investments LLC now owns 10,342,025 shares of the oil and gas company's stock valued at $155,027,000 after purchasing an additional 709,455 shares during the last quarter. 97.81% of the stock is currently owned by hedge funds and other institutional investors.

Core Laboratories Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Monday, May 5th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, May 5th. This represents a $0.04 dividend on an annualized basis and a yield of 0.32%. Core Laboratories's dividend payout ratio is presently 6.78%.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.